Compare NDSN & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NDSN | MEDP |
|---|---|---|
| Founded | 1935 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 14.9B |
| IPO Year | 1998 | 2016 |
| Metric | NDSN | MEDP |
|---|---|---|
| Price | $278.89 | $518.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 13 |
| Target Price | $320.80 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 269.3K | 260.5K |
| Earning Date | 05-27-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | 4.93 | ★ 20.98 |
| EPS | 2.38 | ★ 15.28 |
| Revenue | ★ $2,254,668,000.00 | N/A |
| Revenue This Year | $7.71 | $13.19 |
| Revenue Next Year | $4.96 | $7.75 |
| P/E Ratio | $116.87 | ★ $32.79 |
| Revenue Growth | ★ 9.08 | N/A |
| 52 Week Low | $174.61 | $250.05 |
| 52 Week High | $305.28 | $628.92 |
| Indicator | NDSN | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 63.03 |
| Support Level | $265.04 | $489.09 |
| Resistance Level | $305.28 | $622.32 |
| Average True Range (ATR) | 5.84 | 16.86 |
| MACD | 2.21 | 4.90 |
| Stochastic Oscillator | 90.99 | 87.95 |
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.8 billion in revenue in its fiscal 2025.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.